← All companies

STOK

Stoke Therapeutics, Inc.

STOK Nasdaq Pharmaceutical Preparations EDGAR ↗

$29.56

-0.48 -1.60%

Key statistics

from XBRL data in SEC filings

Market cap

$1.91B

Revenue (TTM)

$27.6M

Net income (TTM)

-$208M

EPS (TTM)

$-3.34

P/E ratio

—

Dividend yield

—

Free cash flow

$44.9M

Cash

$110M

Total assets

$394M

Gross margin

—

52-week range

$12.71 – $40.22

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Aug 3, 2026 10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Regulation FD disclosure; Other events Jun 30, 2026 8-K Shareholder vote results Jun 4, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 7, 2026 8-K Changed accountants Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Director or officer change Mar 3, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jan 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change Oct 6, 2025 8-K/A Shareholder vote results Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Regulation FD disclosure Aug 11, 2025 8-K Regulation FD disclosure Jul 10, 2025 8-K Shareholder vote results Jun 4, 2025 8-K Regulation FD disclosure; Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Mar 18, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Feb 18, 2025 8-K Regulation FD disclosure; Other events Jan 7, 2025 8-K Regulation FD disclosure; Other events Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Other events Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change Jun 21, 2024 8-K Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024